New drug ATX101 takes first step: safety check in healthy people
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called ATX101 in 24 healthy adults aged 18 to 50. Participants received a single dose through a vein, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat any disease, …
Phase: PHASE1 • Sponsor: Aurobac Therapeutics SAS • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:06 UTC